Vireo Growth Inc. SEC filings VREOF
Vireo Growth Inc. has 362 filings in SEC EDGAR's recent list, going back to Apr 1, 2019. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (material agreement, agreement ended, new debt, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Nov 2, 2026 | — |
| 425 | Filing | Oct 22, 2026 | — |
| D | Filing | Oct 7, 2026 | — |
| D | Filing | Oct 2, 2026 | — |
| 425 | Filing | Aug 28, 2026 | — |
| 425 | Filing | Aug 26, 2026 | — |
| 425 | Filing | Aug 25, 2026 | — |
| D | Filing | Aug 24, 2026 | — |
| 425 | Filing | Aug 18, 2026 | — |
| 425 | Filing | Aug 18, 2026 | — |
| 425 | Filing | Aug 13, 2026 | — |
| 425 | Filing | Aug 13, 2026 | — |
| 425 | Filing | Aug 12, 2026 | — |
| 425 | Filing | Aug 11, 2026 | — |
| 425 | Filing | Aug 11, 2026 | — |
| 425 | Filing | Aug 11, 2026 | — |
| 425 | Filing | Jul 30, 2026 | — |
| 425 | Filing | Jul 27, 2026 | — |
| D | Filing | Jun 29, 2026 | — |
| D | Filing | Jun 22, 2026 | — |
| D | Filing | Apr 22, 2026 | — |
| D | Filing | Apr 16, 2026 | — |
| D | Filing | Jan 12, 2026 | — |
| EFFECT | Filing | Dec 19, 2025 | — |
| CORRESP | Letter to the SEC | Dec 18, 2025 | — |
| D | Filing | Oct 23, 2025 | — |
| EFFECT | Filing | Jul 24, 2025 | — |
| CORRESP | Letter to the SEC | Jul 23, 2025 | — |
| D | Filing | Jul 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 18, 2025 | — |
| DEFM14C | Filing | Mar 21, 2025 | — |
| PREM14C | Filing | Mar 11, 2025 | Mar 11, 2025 |
| D | Filing | Jan 7, 2025 | — |
| D | Filing | Nov 12, 2024 | — |
| EFFECT | Filing | Oct 24, 2024 | — |
| CORRESP | Letter to the SEC | Oct 22, 2024 | — |
| CORRESP | Letter to the SEC | Oct 16, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 4, 2024 | — |
| D | Filing | Aug 20, 2024 | — |
| POS EX | Filing | Apr 3, 2024 | — |
| 15-12G | Deregistration | Apr 2, 2024 | — |
| EFFECT | Filing | Aug 10, 2023 | — |
| D | Filing | Aug 10, 2023 | — |
| D | Filing | Aug 10, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2023 | — |
| PRER14A | Filing | Oct 4, 2022 | — |
| PRER14A | Filing | Sep 14, 2022 | — |
| SEC STAFF LETTER | Filing | Feb 3, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2021 | — |
| 10-12G/A | Filing | Jan 20, 2021 | — |
| CORRESP | Letter to the SEC | Jan 19, 2021 | — |
| SEC STAFF LETTER | Filing | Jan 4, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2021 | — |
| 10-12G/A | Filing | Dec 22, 2020 | — |
| CORRESP | Letter to the SEC | Dec 21, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2020 | — |
| 10-12G | Filing | Nov 5, 2020 | — |
| D | Filing | Mar 23, 2020 | — |
| D/A | Filing | Apr 2, 2019 | — |
| D | Filing | Apr 1, 2019 | — |
Showing 61 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VREOF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Minneapolis, MN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1771706
- Former names
- Goodness Growth Holdings, Inc. (until Jun 24, 2024); Vireo Health International, Inc. (until May 14, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.